Abstract:Background: Sickle cell disease is a common genetic disorder characterised by chronic haemolytic anaemia and vaso-occlusive crisis. Sickle cell anaemia (SCA) has both short-term effects in the form of acute clinical events and long-term repercussions seen with chronic multiorgan involvement. It is associated with significant morbidity and mortality. In India, the disease is largely undocumented. Thus, there is an urgent need to highlight the features of the disease so that locally appropriate models of care may be implemented. Objective: This study aims to evaluate acute clinical events in SCA and to provide data that may help to reduce the rate of morbidity and mortality associated with this disease by early interventions. Materials and methods: A cross-sectional observational study was conducted between November 2020 and May 2022 at Indira Gandhi Government Medical College and Hospital, Nagpur, Central India. The inclusion criteria included previously diagnosed patients of SCA (homozygous sickle cell disease) on high-performance liquid chromatography (HPLC) between the age groups of six months and 12 years, presenting with acute clinical events. The exclusion criteria included patients younger than six months and older than 12 years of age, and all patients with other haemoglobinopathies and sickle cell trait. The study was approved by the Institutional Ethical Committee. All the data was entered into a well-designed Microsoft Office Excel spreadsheet (v 2019, Microsoft, Washington, USA). All the clinical, biochemical, and haematological data were tabulated and analysed. Results: A total of 100 children with sickle cell disease diagnosed by HPLC were enrolled during the study period. About 215 acute clinical events among the 100 cases were recorded, for which they were admitted to the paediatric ward or PICU. The majority (35%, n=35) were seen in the age group of six to nine years (school-going age). About 52% were male and 48% were female (male-to-female ratio= 1.08:1). Pain was the most common symptom. The highest incidence of 36.75% (n=79) was seen with acute painful crises and was the most common indication of hospitalisation, followed by acute febrile illness (AFI) (34.42%, n=74), aplastic crisis (10.23%, n=22), splenic sequestration crisis (9.77%, n=21), hepatobiliary involvement (3.72%, n=8), acute chest syndrome and haemolytic crisis (each 1.86%, n=4), and stroke (1.40%, n=3). In cases of having foetal haemoglobin (HbF) ≥20%, the incidence of acute painful crisis (p=0.0001), hand-foot syndrome (p=0.047), aplastic crisis (p=0.033), splenic sequestration crisis (p=0.039), and AFI (p=0.035) was low as compared to cases having HbF ≤20% which was statistically significant. The incidence of acute painful crisis, hand-foot syndrome, and an aplastic crisis was significantly low in patients receiving hydroxyurea therapy as compared to patients who were not on hydroxyurea. Out of 100 cases, four died during the study period, three died because of splenic sequestration crisis with septic shock, and one died due to hepatic encephalopathy due to haemolytic crisis with septic shock. Conclusion: Acute clinical events in sickle cell disease can have significant morbidity and mortality in the paediatric age group. The nutritional status of sickle cell disease children must be given due importance. Early initiation of hydroxyurea must be encouraged to maintain higher HbF levels, which plays a significant role in reducing morbidity.

Intracranial aneurysm in patients with sickle cell disease, a systematic review

Study and Therapeutic Progress on Intracranial Serpentine Aneurysms

Unruptured intracranial aneurysms in pediatric sickle cell disease: clinical and MR imaging follow-up of 296 patients

Intracranial aneurysms in sickle cell disease are associated with hemodynamic stress and anemia

Abstract WP218: Risk Factors for Cerebral Aneurysms in Sickle Cell Disease

Prevalence of Intracranial Stenosis and Silent Cerebral Infarcts in Children with Sickle Cell Anemia and Low Risk of Stroke.

Incidence and Risk Factors for New and Recurrent Infarcts in Adults With Sickle Cell Disease

Acute Pancreatitis in Individuals with Sickle Cell Disease: A Systematic Review

Treatment Options for Complications of Sickle-cell Disease in Children

Recurrent haemorrhagic venous infarct in a patient with sickle cell disease

Incidence, kinetics, and risk factors for intra- and extracranial cerebral arteriopathies in a newborn sickle cell disease cohort early assessed by transcranial and cervical color Doppler ultrasound

Bleeding in patients with sickle cell disease: a population-based study

Neuroimaging and Cognitive Function in Sickle Cell Disease: A Systematic Review

A cross‐sectional, case‐control study of intracranial arterial wall thickness and complete blood count measures in sickle cell disease

Clinical Profiles of Children With Sickle Cell Anaemia Presenting With Acute Clinical Events: A Single-Center Study

Evolution of Extracranial Internal Carotid Artery Disease in Children With Sickle Cell Anemia.

Sickle cell disease as a vascular disorder

The Association Between Sickle Cell Anemia and Cognitive Dysfunction: A Systematic Review

Retrospective Cohort Study of Sickle Cell Disease and Large Vessel Retinal Vascular Occlusion Risk in a National United States Database

The Clinical Characteristics and Treatment Considerations for Intracranial Aneurysms Associated with Middle Cerebral Artery Anomalies: A Systematic Review

Systemic thrombolysis for acute central retinal artery occlusion in sickle cell disease: Case report